Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials95
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a85
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin66
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex65
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies65
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis62
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future54
Visceral leishmaniasis elimination in India: progress and the road ahead50
Neonatal ocular prophylaxis in the United States: is it still necessary?43
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review39
Challenges in preserving antibiotic effectiveness: time for a novel approach38
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72036
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia34
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges32
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies29
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’28
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections25
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China24
Treatment of vaginitis caused by non-albicans Candida species24
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis22
Reemergence of monkeypox: prevention and management22
Identifying predictors of treatment failure with community-acquired pneumonia: an update20
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis20
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections19
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?19
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin19
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline19
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review17
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective17
Diagnostic and clinical management of Candida auris infections in immunocompromised patients17
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges16
Infliximab as a potential treatment for COVID-1916
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development16
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta15
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-1915
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance15
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases15
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges15
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases15
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures15
Diagnostic and management strategies for chronic hepatitis E infection14
Statement of Retraction14
Correction14
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury14
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India14
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches13
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections13
Diagnosing fungal infections in clinical practice: a narrative review13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)13
The serological dilemma: rethinking syphilis treatment evaluation13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana12
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection11
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas11
The evolving debate around screening for Chlamydia trachomatis11
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae11
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review11
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?11
Monoclonal antibodies for the treatment of COVID-19 infection in children11
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations11
Challenges associated with pertussis detection, monitoring, and vaccination in adults11
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae11
How can we tackle the overuse of antibiotics in low- and middle-income countries?10
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?10
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea10
How do we best manage Clostridioides difficle infections in the elderly?10
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition10
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study10
Now that griseofulvin is not available, what to do with tinea capitis treatments?10
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision10
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?9
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-199
Gram-positive infections in special populations. Expert view on the role of dalbavancin9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review9
New insights into the treatment of acute otitis media9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials9
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America9
Tocilizumab for the treatment of COVID-199
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial8
Ivermectin: a pathway out of the pandemic or another dead end?8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan8
Past, present, and future perspectives on aztreonam and avibactam8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options8
Artificial intelligence and prescription of antibiotic therapy: present and future8
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients8
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection8
An update on newer antifungals8
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients8
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance8
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t8
Strengths and caveats of identifying resistance genes from whole genome sequencing data8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo8
0.22355604171753